Meiji Holdings Co., Ltd.
News
- Aug 12, 2020
- HD 【Presentation】Financial Results for the First Quarter of Fiscal Year Ending March 31, 2021
- Aug 12, 2020
- HD Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2021
- Aug 11, 2020
- HD Notice Concerning Completion of Payment in Full for Disposal of Treasury Stock for Restricted Stock Compensation
- July 28, 2020
- HD We updated ESG Data
- July 16, 2020
- HD Notice of the Establishment of a New Production and Sales Company for Dairy Products and Confectionery in China
- July 13, 2020
- HD Notice concerning the Disposal of Treasury Stock for Restricted Stock Compensation
- July 9, 2020
- HD Top Commitment to Sustainability
- June 12, 2020
- HD Approach and Policy Concerning Lowering of Trading Unit
- June 9, 2020
- HD Notice of the 11th Ordinary General Meeting of Shareholders
- May 22, 2020
- HD 【Presentation】Financial Results for the Fiscal Year Ended March 31, 2020
- May 22, 2020
- HD Notice concerning surplus dividends
- May 22, 2020
- HD Consolidated Financial Results for the Fiscal Year Ended March 31, 2020
- May 22, 2020
- HD Meiji Holdings Announces Changes to Representative Director
- May 20, 2020
- FOOD Business partnership using the world’s only technology to make infant formula in tablets. Meiji and Danone enter into a business partnership to produce infant formula tablets for the European market
- Apr 28, 2020
- HD Notice Concerning the Scheduled Date of Announcement of Financial Results for the Fiscal Year Ending March 31, 2020
- Apr 17, 2020
- HD Notice Concerning Postponement of Announcement of Financial Results for the Fiscal Year Ending March 31, 2020
- Apr 15, 2020
- FOOD Notice concerning acquisition of shares of AustAsia Investment Holdings Pte LTD., operating dairy farms in China ～ Secure a stable and high quality milk procurement in China to accelerate Meiji’s Business growth in China ～
- Apr 1, 2020
- HD 2018-2019 Progress Report for Tackling Deforestation in Ghana
- Feb 21, 2020
- PHARMA Support for Control of Novel Coronavirus in China
- Feb 14, 2020
- HD We received a high grade of A- in CDP climate change
- Feb 6, 2020
- HD 【Presentation】Financial Results for the Third Quarter of Fiscal Year Ending March 31, 2020
- Feb 6, 2020
- HD Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2020
- Jan 9, 2020
- PHARMA Meiji and HUYABIO Enter into Exclusive Distribution, License and Collaboration Agreement of HBI-8000 for ATLL and PTCL Treatment in Japan and Certain Asian Countries
- Jan 7, 2020
- HD We updated Standard Table
- Jan 7, 2020
- PHARMA Meiji Seika Pharma and Kadmon Enter into Strategic Partnership to Develop and Commercialize KD025 for GVHD treatment in Japan and Asian Countries